- MHRA touts uptick in approvals in 2025-2026 annual report<p>The UK's Medicines and Healthcare products Regulatory Agency (MHRA) touted its achievements over the last year its 2025-2026 annual report to Parliament, which includes approving more new drugs…raps · 4d ago↗ source
- Biogen’s mixed Alzheimer’s data; Two new startups launch; and moreWelcome back to another edition of Endpoints Weekly! We hope you all have been staying safe indoors as the Canadian wildfires blanketed much of the US Northeast this week. Hopefully things calm dow…Endpoints · 6d ago↗ source
- Midsized biotechs press White House to drop CMS pricing rulesA number of midsized biotech companies have met with White House and HHS officials in the last week, presenting their case for why two pending CMS pricing models could hinder their business and sho…